Aurobindo Pharma says submitted response on Unit-IV, yet hear from USFDA

Unit 4 site located in Pashamylaram, near Hyderabad produces injectable and ophthalmic drugs accounting for 7-8 percent of US sales and has 47 abbreviated new drug application pending for approval.

from Moneycontrol Latest News https://ift.tt/2Saxcax
via IFTTT